Adeshwar Meditex Announces Board Reshuffle and Statutory Auditor Change for AGM

OTHER
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Adeshwar Meditex Announces Board Reshuffle and Statutory Auditor Change for AGM

Adeshwar Meditex Ltd has announced key leadership and governance updates ahead of its 19th Annual General Meeting. The company has appointed Ms. Bhagyalaxmi Kavital as a Non-Executive Independent Director following the resignation of Mr. Prithvi Singh. Furthermore, the board has appointed M/s. Shankar Ramesh & Co. LLP as statutory auditors for a five-year term and confirmed M/s. Saini & Makote as internal auditors for FY 2026-27. The AGM is scheduled for September 23, 2026, with the book closure period set from September 17 to September 23.

Adeshwar Meditex Board and Auditor Overhaul

Key updates: New Independent Director appointed; 5-year statutory auditor term confirmed for Shankar Ramesh & Co.

Reader Takeaway: Governance restructuring ahead of the 19th AGM aims to stabilize board composition and audit oversight.

What just happened

Adeshwar Meditex has formalized a series of administrative and governance changes. The board has appointed Ms. Bhagyalaxmi Kavital as a Non-Executive Independent Director effective August 26, 2026, succeeding Mr. Prithvi Singh, who has resigned. The company also confirmed the appointment of M/s. Shankar Ramesh & Co. LLP as the new statutory auditors for a five-year mandate, pending final shareholder approval at the upcoming AGM.

19th Annual General Meeting

The 19th Annual General Meeting is officially scheduled for September 23, 2026, at 12:30 PM. To facilitate this, the company will close its register of members and share transfer books from September 17 to September 23, 2026, inclusive. Mr. Deep Shukla has been appointed as the scrutinizer to oversee the e-voting process for the meeting.

Auditor Transitions

Beyond the statutory auditor change, the company has transitioned its internal audit function to M/s. Saini & Makote for the financial year 2026-27, following the resignation of the previous firm, M/s. Basude Makote & Saini. The board also reviewed and noted the Director’s Report for the financial year 2025-26, signaling the completion of the annual compliance cycle.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.